Cargando…

Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review

Renal cell carcinoma (RCC) is a common cancer of the urinary system. The potential therapeutic effects of certain natural products against renal cell carcinoma have been reported both in vivo and in vitro, but no reviews have been published classifying and summarizing the mechanisms of action of var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Chenchen, Lyu, Yinfeng, Gong, Lingxiao, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182762/ https://www.ncbi.nlm.nih.gov/pubmed/35684073 http://dx.doi.org/10.3390/nu14112274

Ejemplares similares

Arborinine from Glycosmis parva leaf extract inhibits clear-cell renal cell carcinoma by inhibiting KDM1A/UBE2O signaling
por: Feng, Chenchen, et al.
Publicado: (2022)

Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma
por: Wang, Liang, et al.
Publicado: (2020)

PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
por: Feng, Chenchen, et al.
Publicado: (2021)

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
por: Feng, Chenchen, et al.
Publicado: (2021)

Development of a Phagocytosis-Dependent Gene Signature to Predict Prognosis and Response to Checkpoint Inhibition in Clear-Cell Renal Cell Carcinoma
por: Li, Kunping, et al.
Publicado: (2022)

Corrigendum: Development of a phagocytosis- dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma
por: Li, Kunping, et al.
Publicado: (2023)

BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
por: Lyu, Yinfeng, et al.
Publicado: (2021)

Correction to: BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
por: Lyu, Yinfeng, et al.
Publicado: (2023)

Therapeutic Potential of Natural Products in the Treatment of Schistosomiasis
por: Azevedo, Carine Machado, et al.
Publicado: (2023)

Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review
por: Park, Seung-Hyeok, et al.
Publicado: (2021)

Natural products: potential drugs for the treatment of renal fibrosis
por: Zhou, Zijun, et al.
Publicado: (2022)

ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2021)

Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2023)

Correction: Natural products: potential drugs for the treatment of renal fibrosis
por: Zhou, Zijun, et al.
Publicado: (2022)

Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer's Disease
por: Chakraborty, Biswajit, et al.
Publicado: (2022)

The role of hyaluronan in renal cell carcinoma
por: Jin, Chenchen, et al.
Publicado: (2023)

Discovery of Novel Natural Products with Therapeutic Potential
por: Gullo, Vincent
Publicado: (2013)

The Discovery of Marine Natural Products with Therapeutic Potential
por: Oliver, J.McConnell, et al.
Publicado: (1994)

COVID-19 Therapeutic Potential of Natural Products
por: Low, Zhaoxuan, et al.
Publicado: (2023)

The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma()
por: Wang, Xiaoen, et al.
Publicado: (2014)

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma
por: Cuvillier, Olivier
Publicado: (2017)

Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma
por: Chow, Mathilda Jing, et al.
Publicado: (2021)

Editorial: New Insights Into Renal Fibrosis and Therapeutic Effects of Natural Products
por: Xu, Ying, et al.
Publicado: (2022)

The therapeutic potential of natural products for treating pancreatic cancer
por: He, Xia, et al.
Publicado: (2022)

Targeting ferroptosis in renal cell carcinoma: Potential mechanisms and novel therapeutics
por: Yang, Lei, et al.
Publicado: (2023)

Narrative Review: Bioactive Potential of Various Mushrooms as the Treasure of Versatile Therapeutic Natural Product
por: Chopra, Hitesh, et al.
Publicado: (2021)

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis
por: Hasan, Mahbub, et al.
Publicado: (2022)

Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products
por: Tan, Wei, et al.
Publicado: (2022)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
por: Yao, Lei, et al.
Publicado: (2022)

Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma
por: Lu, Lu, et al.
Publicado: (2019)

Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities
por: Mahmoud, Ahmed M, et al.
Publicado: (2023)

Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses
por: Ren, Xiang-bin, et al.
Publicado: (2021)

Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
por: Gras Navarro, Andrea, et al.
Publicado: (2015)

Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells
por: Rahman, Md. Ataur, et al.
Publicado: (2020)

Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications
por: Sun, Jiaao, et al.
Publicado: (2023)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma
por: Yu, H, et al.
Publicado: (2015)

Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas
por: Caliskan, Aysegul, et al.
Publicado: (2021)

Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer
por: Al-Bari, Md. Abdul Alim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_97hbb1hal2i2khe1vslubkk8ud